VHCP Management II as of Sept. 30, 2019
Portfolio Holdings for VHCP Management II
VHCP Management II holds 21 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| 10x Genomics Inc Cl A (TXG) | 34.3 | $90M | 1.8M | 50.40 | |
| Biohaven Pharmaceutical Holding | 11.3 | $30M | 713k | 41.72 | |
| Ascendis Pharma A S (ASND) | 8.6 | $23M | 235k | 96.32 | |
| Shockwave Med (SWAV) | 7.4 | $19M | 646k | 29.93 | |
| Obseva Sa | 7.2 | $19M | 2.3M | 8.33 | |
| Axsome Therapeutics (AXSM) | 6.9 | $18M | 893k | 20.24 | |
| Ra Pharmaceuticals | 6.1 | $16M | 677k | 23.65 | |
| BioCryst Pharmaceuticals (BCRX) | 3.1 | $8.3M | 2.9M | 2.87 | |
| Protagonist Therapeutics (PTGX) | 1.9 | $5.1M | 427k | 12.01 | |
| Spero Therapeutics (SPRO) | 1.9 | $5.0M | 474k | 10.60 | |
| Constellation Pharmceticls I | 1.8 | $4.7M | 727k | 6.46 | |
| Kiniksa Pharmaceuticals (KNSA) | 1.8 | $4.6M | 541k | 8.51 | |
| La Jolla Pharmaceuticl Com Par | 1.7 | $4.6M | 518k | 8.80 | |
| Kalvista Pharmaceuticals (KALV) | 1.7 | $4.4M | 377k | 11.60 | |
| Tricida | 1.4 | $3.7M | 119k | 30.87 | |
| Milestone Pharmaceuticals (MIST) | 1.1 | $2.8M | 149k | 18.65 | |
| Marinus Pharmaceuticals | 0.9 | $2.3M | 1.5M | 1.54 | |
| Bellerophon Therapeutics | 0.8 | $2.0M | 4.1M | 0.48 | |
| Radius Health | 0.1 | $352k | 14k | 25.76 | |
| Proteostasis Therapeutics In | 0.0 | $110k | 131k | 0.84 | |
| Prevail Therapeutics Ord | 0.0 | $32k | 2.6k | 12.29 |
